항부정맥제 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "항부정맥제" in Korean language version.

refsWebsite

Global rank Korean rank

15nih.gov

4^th place

13doi.org

2^nd place

3^rd place

9archive.org

6^th place

18^th place

5semanticscholar.org

11^th place

310^th place

2gpnotebook.co.uk

low place

9,253^rd place

1books.google.com

3^rd place

9^th place

1medscape.com

719^th place

424^th place

archive.org (Global: 6^th place; Korean: 18^th place)

Unless else specified in boxes, then ref is: Rang, H. P. (2003). 《Pharmacology》. Edinburgh: Churchill Livingstone. ISBN 978-0-443-07145-4.
Kulmatycki KM, Abouchehade K, Sattari S, Jamali F (May 2001). “Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat”. 《Br. J. Pharmacol.》 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.
Trevor, Anthony J.; Katzung, Bertram G. (2003). 《Pharmacology》. New York: Lange Medical Books/McGraw-Hill, Medical Publishing Division. 43쪽. ISBN 978-0-07-139930-2.
Lenz, TL; Hilleman, DE (2000). “Dofetilide, a New Class III Antiarrhythmic Agent”. 《Pharmacotherapy》 20 (7): 776–86. doi:10.1592/phco.20.9.776.35208. PMID 10907968. S2CID 19897963.
Conti JB, Belardinelli L, Utterback DB, Curtis AB (March 1995). “Endogenous adenosine is an antiarrhythmic agent”. 《Circulation》 91 (6): 1761–67. doi:10.1161/01.cir.91.6.1761. PMID 7882485.
Lindberg JS, Zobitz MM, Poindexter JR, Pak CY (1990). “Magnesium bioavailability from magnesium citrate and magnesium oxide”. 《Journal of the American College of Nutrition》 9 (1): 48–55. doi:10.1080/07315724.1990.10720349. PMID 2407766.
Singh, BN; Vaughan Williams, EM (August 1970). “The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.”. 《British Journal of Pharmacology》 39 (4): 657–67. doi:10.1111/j.1476-5381.1970.tb09891.x. PMC 1702721. PMID 5485142.
Vaughan Williams EM (November 1992). “Classifying antiarrhythmic actions: by facts or speculation”. 《J Clin Pharmacol》 32 (11): 964–77. doi:10.1002/j.1552-4604.1992.tb03797.x. PMID 1474169. S2CID 70464824.
Fogoros, Richard N. (1997). 《Antiarrhythmic drugs: a practical guide》. Oxford: Blackwell Science. 49쪽. ISBN 978-0-86542-532-3.

books.google.com (Global: 3^rd place; Korean: 9^th place)

Waller, Derek G.; Sampson, Tony (2013). 《Medical Pharmacology and Therapeutics E-Book》 (영어). Elsevier Health Sciences. 144쪽. ISBN 9780702055034.

doi.org (Global: 2^nd place; Korean: 3^rd place)

dx.doi.org

Kloner RA (2009). “A Salute to Our Founding Editor-in-Chief Bramah N. Singh, MD, DPhil, DSc, FRCP”. 《Journal of Cardiovascular Pharmacology and Therapeutics》 14 (3): 154–56. doi:10.1177/1074248409343182. PMID 19721129. S2CID 44733401.
Kulmatycki KM, Abouchehade K, Sattari S, Jamali F (May 2001). “Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat”. 《Br. J. Pharmacol.》 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.
Milne JR, Hellestrand KJ, Bexton RS, Burnett PJ, Debbas NM, Camm AJ (February 1984). “Class 1 antiarrhythmic drugs – characteristic electrocardiographic differences when assessed by atrial and ventricular pacing”. 《Eur. Heart J.》 5 (2): 99–107. doi:10.1093/oxfordjournals.eurheartj.a061633. PMID 6723689.
Lenz, TL; Hilleman, DE (2000). “Dofetilide, a New Class III Antiarrhythmic Agent”. 《Pharmacotherapy》 20 (7): 776–86. doi:10.1592/phco.20.9.776.35208. PMID 10907968. S2CID 19897963.
Conti JB, Belardinelli L, Utterback DB, Curtis AB (March 1995). “Endogenous adenosine is an antiarrhythmic agent”. 《Circulation》 91 (6): 1761–67. doi:10.1161/01.cir.91.6.1761. PMID 7882485.
Brugada P (July 2000). “Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias”. 《Eur. Heart J.》 21 (14): 1116. doi:10.1053/euhj.2000.2142. PMID 10924290.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). “Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《J Am Coll Nutr》 23 (5): 497S–500S. doi:10.1080/07315724.2004.10719388. PMID 15466950. S2CID 30146333.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (April 2006). “Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《Pediatr Int》 48 (2): 112–17. doi:10.1111/j.1442-200X.2006.02177.x. PMID 16635167. S2CID 24904388.
Lindberg JS, Zobitz MM, Poindexter JR, Pak CY (1990). “Magnesium bioavailability from magnesium citrate and magnesium oxide”. 《Journal of the American College of Nutrition》 9 (1): 48–55. doi:10.1080/07315724.1990.10720349. PMID 2407766.
Singh, BN; Vaughan Williams, EM (August 1970). “The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.”. 《British Journal of Pharmacology》 39 (4): 657–67. doi:10.1111/j.1476-5381.1970.tb09891.x. PMC 1702721. PMID 5485142.
Damato, Anthony N. (1969년 7월 1일). “Diphenylhydantoin: Pharmacological and clinical use”. 《Progress in Cardiovascular Diseases》 12 (1): 1–15. doi:10.1016/0033-0620(69)90032-2. PMID 5807584.
Vaughan Williams EM (November 1992). “Classifying antiarrhythmic actions: by facts or speculation”. 《J Clin Pharmacol》 32 (11): 964–77. doi:10.1002/j.1552-4604.1992.tb03797.x. PMID 1474169. S2CID 70464824.
Lei, Ming; Wu, Lin; Terrar, Derek A.; Huang, Christopher L.-H. (2018년 10월 23일). “Modernized Classification of Cardiac Antiarrhythmic Drugs”. 《Circulation》 138 (17): 1879–1896. doi:10.1161/CIRCULATIONAHA.118.035455. PMID 30354657.

gpnotebook.co.uk (Global: low place; Korean: 9,253^rd place)

“treatment of paroxysmal atrial fibrillation - General Practice Notebook”. 《www.gpnotebook.co.uk》.
“protocol for management of haemodynamically stable ventricular tachycardia – General Practice Notebook”. 《www.gpnotebook.co.uk》. 2016년 2월 9일에 확인함.

medscape.com (Global: 719^th place; Korean: 424^th place)

“Milestones in the Evolution of the Study of Arrhythmias”. 2008년 7월 31일에 확인함. ^{[깨진 링크]}

nih.gov (Global: 4^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Kloner RA (2009). “A Salute to Our Founding Editor-in-Chief Bramah N. Singh, MD, DPhil, DSc, FRCP”. 《Journal of Cardiovascular Pharmacology and Therapeutics》 14 (3): 154–56. doi:10.1177/1074248409343182. PMID 19721129. S2CID 44733401.
Kulmatycki KM, Abouchehade K, Sattari S, Jamali F (May 2001). “Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat”. 《Br. J. Pharmacol.》 133 (2): 286–94. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.
Milne JR, Hellestrand KJ, Bexton RS, Burnett PJ, Debbas NM, Camm AJ (February 1984). “Class 1 antiarrhythmic drugs – characteristic electrocardiographic differences when assessed by atrial and ventricular pacing”. 《Eur. Heart J.》 5 (2): 99–107. doi:10.1093/oxfordjournals.eurheartj.a061633. PMID 6723689.
Lenz, TL; Hilleman, DE (2000). “Dofetilide, a New Class III Antiarrhythmic Agent”. 《Pharmacotherapy》 20 (7): 776–86. doi:10.1592/phco.20.9.776.35208. PMID 10907968. S2CID 19897963.
Conti JB, Belardinelli L, Utterback DB, Curtis AB (March 1995). “Endogenous adenosine is an antiarrhythmic agent”. 《Circulation》 91 (6): 1761–67. doi:10.1161/01.cir.91.6.1761. PMID 7882485.
Brugada P (July 2000). “Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias”. 《Eur. Heart J.》 21 (14): 1116. doi:10.1053/euhj.2000.2142. PMID 10924290.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). “Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《J Am Coll Nutr》 23 (5): 497S–500S. doi:10.1080/07315724.2004.10719388. PMID 15466950. S2CID 30146333.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (April 2006). “Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《Pediatr Int》 48 (2): 112–17. doi:10.1111/j.1442-200X.2006.02177.x. PMID 16635167. S2CID 24904388.
Lindberg JS, Zobitz MM, Poindexter JR, Pak CY (1990). “Magnesium bioavailability from magnesium citrate and magnesium oxide”. 《Journal of the American College of Nutrition》 9 (1): 48–55. doi:10.1080/07315724.1990.10720349. PMID 2407766.
Charlier, R; Deltour, G; Baudine, A; Chaillet, F (November 1968). “Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.”. 《Arzneimittel-Forschung》 18 (11): 1408–17. PMID 5755904.
Singh, BN; Vaughan Williams, EM (August 1970). “The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.”. 《British Journal of Pharmacology》 39 (4): 657–67. doi:10.1111/j.1476-5381.1970.tb09891.x. PMC 1702721. PMID 5485142.
Damato, Anthony N. (1969년 7월 1일). “Diphenylhydantoin: Pharmacological and clinical use”. 《Progress in Cardiovascular Diseases》 12 (1): 1–15. doi:10.1016/0033-0620(69)90032-2. PMID 5807584.
“The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology”. 《Eur. Heart J.》 12 (10): 1112–31. October 1991. PMID 1723682.
Vaughan Williams EM (November 1992). “Classifying antiarrhythmic actions: by facts or speculation”. 《J Clin Pharmacol》 32 (11): 964–77. doi:10.1002/j.1552-4604.1992.tb03797.x. PMID 1474169. S2CID 70464824.
Lei, Ming; Wu, Lin; Terrar, Derek A.; Huang, Christopher L.-H. (2018년 10월 23일). “Modernized Classification of Cardiac Antiarrhythmic Drugs”. 《Circulation》 138 (17): 1879–1896. doi:10.1161/CIRCULATIONAHA.118.035455. PMID 30354657.

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

api.semanticscholar.org

Kloner RA (2009). “A Salute to Our Founding Editor-in-Chief Bramah N. Singh, MD, DPhil, DSc, FRCP”. 《Journal of Cardiovascular Pharmacology and Therapeutics》 14 (3): 154–56. doi:10.1177/1074248409343182. PMID 19721129. S2CID 44733401.
Lenz, TL; Hilleman, DE (2000). “Dofetilide, a New Class III Antiarrhythmic Agent”. 《Pharmacotherapy》 20 (7): 776–86. doi:10.1592/phco.20.9.776.35208. PMID 10907968. S2CID 19897963.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). “Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《J Am Coll Nutr》 23 (5): 497S–500S. doi:10.1080/07315724.2004.10719388. PMID 15466950. S2CID 30146333.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (April 2006). “Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《Pediatr Int》 48 (2): 112–17. doi:10.1111/j.1442-200X.2006.02177.x. PMID 16635167. S2CID 24904388.
Vaughan Williams EM (November 1992). “Classifying antiarrhythmic actions: by facts or speculation”. 《J Clin Pharmacol》 32 (11): 964–77. doi:10.1002/j.1552-4604.1992.tb03797.x. PMID 1474169. S2CID 70464824.

항부정맥제 (Korean Wikipedia)

archive.org (Global: 6th place; Korean: 18th place)

books.google.com (Global: 3rd place; Korean: 9th place)

doi.org (Global: 2nd place; Korean: 3rd place)